LAGUNA HILLS, Calif., April 03, 2017 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced the appointment of Mark L. Rabe, MD, as Director of Cannabis Program Development. In his new role, Dr. Rabe ...
The post PharmaCyte Biotech Appoints Dr. Mark Rabe Director of Cannabis Program Development appeared first on ForexTV.
April 03, 2017 at 06:40PM
http://ift.tt/2otkciw
from Nasdaq NewsFeed
http://ift.tt/2otkciw
No comments:
Post a Comment